KLH.V Key Stats
|Revenue (Quarterly YoY Growth)||-45.44%|
|EPS Diluted (TTM)||-0.3549|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-20.46M|
|Gross Profit Margin (Quarterly)||-105.7%|
|Profit Margin (Quarterly)||-9093%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
KLH.V Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Stellar Biotechnologies is up 195.0% over the last year vs and S&P 500 Total Return up 24.54%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for KLH.V
Pro Strategies Featuring KLH.V
Did Stellar Biotechnologies make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: California
- Incorporation Country: Canada
- Incorporation State/Province: N/A
Stellar Biotechnologies, Inc. is in the production of KLH, an immuno-stimulatory protein used in vaccines & other biomedical products. Its customers and co-research partners include multi-national pharmaceutical companies and among others.